Machine Learning Model to predict survival in AML patients
Created by: Steve Tungjitviboonkun, MD
Prototype only. This tool is for research and demonstration purposes and is not intended for clinical decision-making.
Patient inputs
Age at diagnosis (limit 18 to 88)
Sex
Male
Female
ELN 2017
Favorable
Intermediate
Adverse
Disease type
De novo
Therapy-related
Chromosome
Normal
Complex
FLT3-ITD mutation
Positive
Negative
Unknown
NPM1 mutation
Positive
Negative
Unknown
RUNX1 mutation
Positive
Negative
Unknown
ASXL1 mutation
Positive
Negative
Unknown
TP53 mutation
Positive
Negative
Unknown
Predict
Results will appear after prediction.
Survival prediction
Time
% probability of survival
6 months
—
12 months
—
18 months
—
24 months
—